S&P Futures
6,000.25 -6.25 (-0.10%) Dow Futures
44,789.00 -37.00 (-0.08%) Nasdaq Futures
20,860.25 -20.00 (-0.10%) Russell 2000 Futures
2,437.90 -13.10 (-0.53%) Crude Oil
69.03 +0.09 (+0.13%) Gold
2,629.30 +10.80 (+0.41%)
Inspire Medical Systems, Inc. (INSP)
After hours:
- Simply Wall St.
US Stocks That May Be Priced Below Their Intrinsic Value In November 2024
As the United States stock market continues its upward momentum, with the S&P 500 extending its winning streak and major indices near record highs, investors are keenly observing opportunities to identify stocks that may be priced below their intrinsic value. In this environment of optimism and growth, understanding the fundamentals that make a stock potentially undervalued becomes crucial for those looking to capitalize on discrepancies between market price and intrinsic worth.
- Benzinga
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
BofA Securities has upgraded Inspire Medical Systems, Inc. (NYSE:INSP) and says the company now falls in the profitable growth category. Inspire Medical is expected to give its 2025 revenue guidance in early January, likely alongside its fourth-quarter results. The company has already stated that it is comfortable with the Street’s consensus of $950 million in revenue for 2025. For 2024, the company expects sales of $793 million – $798 million compared to prior guidance of $788 million – $798 mi
